Australia's INOVIQ rises on positive cancer treatment lab results

Inoviq

18/06/2025 01:38

** Shares of INOVIQ IIQ.AX rise 14.8% to A$0.445, their highest levels since June 10

** The pharmaceutical co says its new cancer treatment kills 88% of breast and lung cancer cells in lab tests

** Around 436,144 shares change hands, vs the 30-day average of 300,505 shares

** Earlier in the day, stock hit its biggest intraday gain since early June

** Stock down 16.5% this year, including the day's move

 (Reporting by Shivangi Lahiri in Bengaluru)

 ((shivangi.lahiri@thomsonreuters.com))